Search Results - "Ning, Changwen"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Folate transporter dynamics and therapy with classic and tumor-targeted antifolates by O’Connor, Carrie, Wallace-Povirk, Adrianne, Ning, Changwen, Frühauf, Josephine, Tong, Nian, Gangjee, Aleem, Matherly, Larry H., Hou, Zhanjun

    Published in Scientific reports (18-03-2021)
    “…There are three major folate uptake systems in human tissues and tumors, including the reduced folate carrier (RFC), folate receptors (FRs) and proton-coupled…”
    Get full text
    Journal Article
  2. 2

    Immune inhibitory receptor-mediated immune response, metabolic adaptation, and clinical characterization in patients with COVID-19 by An, Huaying, Yan, Congrui, Ma, Jun, Gong, Jiayuan, Gao, Fenghua, Ning, Changwen, Wang, Fei, Zhang, Meng, Li, Baoyi, Su, Yunqi, Liu, Pengyu, Wei, Hanqi, Jiang, Xingwei, Yu, Qun

    Published in Scientific reports (06-11-2023)
    “…Immune inhibitory receptors (IRs) play a critical role in the regulation of immune responses to various respiratory viral infections. However, in coronavirus…”
    Get full text
    Journal Article
  3. 3

    Natural plant flavonoid apigenin directly disrupts Hsp90/Cdc37 complex and inhibits pancreatic cancer cell growth and migration by He, Jing, Ning, Changwen, Wang, Yu, Ma, Tianfang, Huang, He, Ge, Yubin, Liu, Jingbo, Jiang, Yiqun

    Published in Journal of functional foods (01-10-2015)
    “…•Apigenin can be digested, released and absorbed into blood circulation to accumulate.•Apigenin directly inhibited Hsp90/Cdc37 interaction with structural…”
    Get full text
    Journal Article
  4. 4

    Abstract 4791: Impact of folate transport redundancies on the therapy with tumor-targeted and untargeted antifolates by Hou, Zhanjun, O’Connor, Carrie, Ning, Changwen, Wallace-Povirk, Adrianne, Frühauf, Josephine, Nayeen, Md. Junayed, Gangjee, Aleem, Matherly, Larry H.

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract Folates participate in one-carbon (C1) transfer reactions in normal and cancer cells. Antifolate therapeutics disrupt cytosolic C1 metabolism, and…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer by Ning, Changwen, Liang, Min, Liu, Shuang, Wang, Guan, Edwards, Holly, Xia, Yang, Polin, Lisa, Dyson, Gregory, Taub, Jeffrey W, Mohammad, Ramzi M, Azmi, Asfar S, Zhao, Lijing, Ge, Yubin

    Published in Oncotarget (04-07-2017)
    “…Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease in urgent need of newer therapeutic modalities. Majority of patients with PDAC have mutations in…”
    Get full text
    Journal Article
  10. 10
  11. 11